Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Bromelain
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase III
Sponsor : MediWound
Deal Size : Undisclosed
Deal Type : Agreement
Details : The agreement is part of MediWound's global commercialization strategy that will expand the medical and commercial potential of NexoBrid to treat skin burns.
Product Name : Undisclosed
Product Type : Enzyme
Upfront Cash : Undisclosed
February 01, 2020
Lead Product(s) : Bromelain
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase III
Sponsor : MediWound
Deal Size : Undisclosed
Deal Type : Agreement